Introduction
Over 80% cases of nephrotic syndrome (NS) in children are due to minimal change disease and most respond to steroid therapy 1 . Steroid sensitive NS rarely progresses to end stage renal failure, over 80% entering spontaneous long term remission in later childhood 2 . In contrast, steroid resistant and refractory NS have an unfavourable outcome often progressing to end stage renal failure 3, 4 . Infection is a universal concern in patients receiving cytotoxic or immunosuppressive therapy. Concomitant glucocorticoid therapy adds to this problem and the risk of infection with cytomegalovirus, Pneumocystis carinii, and varicella zoster is always present 5 . It is well known that severe attack of measles can re-activate tuberculosis 6 and this case report describes its reactivation following immunosuppressive therapy for NS. Oral corticosteroid therapy was continued at 60mg/m 2 on alternate days for 4 weeks tapering 10mg/m 2 monthly. Oedema was initially controlled with the use of diuretics and after the second pulse of cyclophosphamide the child finally entered complete remission. After being in remission for 5 days, he was to be discharged after a prolonged hospital stay. However, on the day of discharge before leaving hospital he became unwell with cough and vomiting. He was commenced of intravenous fluids and the initial chest x-ray revealed opacities of the right lung with hilar lymphadenopathy (figure 1). His erythrocyte sedimentation rate was 133mm in the first hour and the polymerase chain reaction for Mycobacterium tuberculosis was positive in blood. The patient succumbed and the postmortem examination revealed disseminated tuberculosis.
Case report

Discussion
The activation of indolent TB during immunosuppressive therapy has received much emphasis in the western literature 7, 8 but has always been a cause for concern in India. It is important to have a high degree of suspicion of the possibility of re-activation of TB during heavy immunosuppressive therapy especially in steroid resistant disease. Cytotoxic and immunosuppressive drugs while playing a pivotal role in induction and maintenance of remission in some types of NS in children, are themselves associated with significant morbidity. The risk of associated side effects is more pronounced in steroid resistant nephrotic syndrome (SRNS) and steroid dependent nephrotic syndrome (SDNS) where children are exposed to multiple courses of high-dose prednisolone. Glucocorticoids are known to strongly reduce the production of cytokines IL-1β and TNF-α, and many immunomodulatory cytokines such as IL-2, IL-10, IL-12 and IFN-γ whereas cyclosporine and tacrolimus inhibit T cell function and IL-2 production 9 . TNF-α is a key cytokine in host defence mechanism against Mycobacterium tuberculosis 10 . Prolonged treatment with cytotoxic drugs such as cyclophosphamide and chlorambucil also places the patient at highly immunocompromised state. In a person with latent TB infection, such a shift in the immunological status can cause the M. tuberculosis bacteria to multiply further, resulting in disease which manifests as active TB 11 .
Given this proven increased risk of TB activation, screening patients for latent infection should take place before starting longterm immunosuppressive therapy. However currently a gold standard for such screening is lacking. The two main available tests are the tuberculin skin test (TST) and interferon-γ release assays (IGRAs). Though TST shows high sensitivity in individuals with normal immune responses 12 the sensitivity in people with previous Bacille Calmette-Guérin (BCG) vaccination, prior exposure to nontuberculous mycobacteria and immunosuppressant medication is lower 7 . Though some studies suggest the T-SPOT blood test which is a type of IGRA to diagnose latent TB 7, 13 , a study by Ratnatunga et al in Sri Lanka showed no advantage in using T-SPOT.TB over TST 14 . The TST is the most widely used method for TB screening in these settings due to the significant advantage of low cost.
Despite the lack of a golden standard, the need for TB screening prior to heavy immunosuppressive therapy especially in children, remains important. Tuberculosis skin test, smear microscopy and chest radiography could be employed for this purpose, preferably after an individual risk assessment for each patient. It should also be taken into account that prophylactic therapy for TB carries a low risk of hepatotoxicity, which is also an undesirable side-effect of cyclophosphamide 15 .
